Discussions on research integrity often focus on when researchers should be taught about the principles of good research conduct and the perils of questionable practices and misconduct. Many would say that this teaching is essential for PhD students and early-career researchers. Others argue that it should be taught earlier, at the undergraduate stage. They feel […]
It can be challenging to investigate allegations of research misconduct. Investigations must be thorough, objective and fair, and carried out in a timely manner using a transparent process. They must be in accordance with the law, meet the requirements of regulatory and funding bodies, and show due sensitivity and confidentiality to those involved. Investigating allegations relating […]
From the RCUK website: the Research Councils Internal Audit Service (RCIAS) has merged with RCUK Assurance to create a single audit and assurance body. The new merged organisation is called Audit and Assurance Services Group (AASG) which reflects its new combined assurance role and the variety of customers it now serves. The main activities of […]
The Times of India discusses claims that some drug companies have been writing scientific recommendations of their own products and submitting them to the Drug Controller General of India after getting them endorsed by top doctors for a quicker marketing approval: Times of India: Drugs Scam The Vancouver Sun discusses how excessive competitiveness and other […]
UKRIO has responded to the consultation on the draft ‘Concordat to Support Research Integrity’. We welcome the Concordat and hope it signals a collective determination to show that the UK research community understands the pressures which undermine sound science and remains a champion of research integrity. Our response poses a number of a number of […]
The MHRA has posted information on new pharmacovigilance legislation coming into effect across the EU in July 2012. The changes introduced by the EU Directive will be transposed into UK law in the Human Medicines Regulations 2012, which will also consolidate nearly all other UK medicines legislation. The legislation will be underpinned by an EC […]